The Beijing-Tianjin-Hebei "3+N" Alliance Launches the Joint Purchase of Coronary Drug Balloons and Pacemaker Medical Consumables

On September 8, Tianjin Medical Purchasing Center issued the "Notice on Carrying out the Joint Procurement of Coronary Drug Balloons and Pacemaker Medical Consumables in the Beijing-Tianjin-Hebei "3+N" Alliance", Beijing-Tianjin-Hebei Medical The security department has formed a "3+N" alliance with the voluntarily joined regions such as Heiji, Liao, Mengjin, Shandong, Henan, Sichuan, Guizhou and Tibet, and launched the Beijing-Tianjin-Hebei "3+N" alliance for coronary drug balloons and pacemaker medical consumables belts Quantity linkage procurement projects
.
Among them, the procurement subjects in Beijing have implemented the results of the selection of coronary drug balloons and will no longer participate; the procurement subjects in Shandong only participate in the implementation of the results of the selection of coronary drug balloons; the procurement subjects in Shanxi, Henan and Guizhou only participate in the implementation of pacemakers Winning result

The purchased products are coronary drug balloons and pacemakers.
The purchase agreement is signed for one year for the first time
.
In principle, the purchase amount for renewed purchase agreements is determined on a pro rata basis .

Attached:

Notice on Carrying out the Linkage Procurement of Coronary Drug Balloons and Pacemaker Medical Consumables in the Beijing-Tianjin-Hebei "3+N" Alliance

All relevant units:

In order to implement the "Opinions of the Central Committee of the Communist Party of China and the State Council on Deepening the Reform of the Medical Security System" (Zhongfa [2020] No.
5), the "Notice of the General Office of the State Council on Printing and Distributing the Reform Plan for the Governance of High-Value Medical Consumables" (issued by the State Council (2019) 37 No.
), "Guiding Opinions on the Development of Centralized Purchase and Use of High-Value Medical Consumables by National Organizations" (Yibaofa [2021] No.
31) and other documents, to give full play to the leadership of centralized procurement in deepening the reform of the medical service supply side To promote the reform of the centralized procurement of high-value medical consumables, refer to the "Opinions on the Joint Procurement of Medicines in Beijing-Tianjin-Hebei" (Jingyibaofa [2020] No.
34) and other documents, after the Beijing-Tianjin-Hebei medical security department researched and decided, and Voluntarily joined regions such as Heiji, Liao, Mengjin, Shandong, Henan, Sichuan, Guizhou and Tibet formed a "3+N" alliance to carry out the joint procurement of coronary drug balloons and pacemaker medical consumables in the Beijing-Tianjin-Hebei "3+N" alliance The project, the relevant work notification is as follows:

1.
Work organization

Beijing Municipal Pharmaceutical Centralized Purchasing Service Center, together with Tianjin Pharmaceutical Purchasing Center and Hebei Medical Pharmaceutical Equipment Centralized Purchasing Center (hereinafter collectively referred to as "Beijing-Tianjin-Hebei Purchasing Center"), acted as the joint procurement agency for medical consumables, responsible for project procurement.
Specific implementation
.
The medical security department of the Beijing-Tianjin-Hebei "3+N" alliance area is responsible for formulating and implementing the results of the regional implementation of the selection and supporting policies, etc.

2.
Procurement subject

All public medical institutions (including military medical institutions, the same below) in the Beijing-Tianjin-Hebei "3+N" alliance area form a procurement alliance, as the main procurement body of each region, to implement this joint procurement with a large amount
.
Other medical institutions voluntarily participate in accordance with the relevant regulations of the alliance area

Three, purchase varieties

(1) Coronary drug balloons refer to the first 15 digits of the National Medical Insurance Bureau's medical insurance medical consumables code as C02020600200001 and C02020600200002
.
Purchasing units are distinguished by registration certificates, and the same purchasing unit contains all specifications and models

(2) Pacemakers refer to the first 15 digits of the National Medical Insurance Bureau's medical insurance medical consumables code as C02040205800001, C02040205800002, C02040205800003, C02040205800005 and C02040205800006
.
Purchasing units are distinguished according to registration certificates and functional attributes.

Fourth, the procurement cycle

The Beijing-Tianjin-Hebei "3+N" Alliance’s centralized procurement cycle of coronary drug balloons and pacemaker medical consumables is aligned with the national organization’s centralized procurement cycle of coronary stents
.
The purchase agreement is signed for the first time for one year, and the purchase amount for renewal of the purchase agreement is determined on a pro rata basis in principle

5.
Purchasing method

This time, the centralized procurement method of coronary drug balloons and pacemaker medical consumables is the linkage of the quantity and the two-way selection, that is, according to the use needs of the procurement subject, the overall price level of the market, comprehensive quality and other factors, linking the provinces of the country (District, city) The purchase price with quantity is selected by the buyer and the seller, the quantity is exchanged for the price, the selected products and the subcontracting task quantity are determined, and the quantity purchase and supporting policies are implemented
.

Six, enterprise declaration requirements

(1) The reporting enterprise shall abide by relevant laws and regulations such as the Patent Law of the People's Republic of China and the Anti-Unfair Competition Law of the People's Republic of China
.
Medical device registrants who have obtained the legal qualifications of coronary drug balloons and pacemaker products can participate as applicants

(2) The declared product shall belong to the scope of purchased varieties and obtain a valid medical device registration certificate of the People’s Republic of China, comply with the quality standard requirements of relevant national departments, and organize production in accordance with the requirements of relevant national departments
.

(3) The applying enterprise shall participate within the specified time and complete relevant system operations
.
It should be promised that all specifications and models in the selected product registration certificate will meet the procurement needs of the alliance area during the procurement cycle, maintain the continuity of the accompanying service supply before and after the mass linkage procurement, maintain the existing service content and fee standards, and agree that the relevant credit commitments can be based on work needs Make it public

(4) This volume-linked procurement work relies on the Beijing Municipal Medical Consumables Sunshine Procurement Platform (https://hc.
bjmbc.
org.
cn:1000/, referred to as the Beijing Platform, the same below) and the Beijing-Tianjin-Hebei Pharmaceutical Joint Procurement Platform ( https://hc.
tjmpc.
cn:17055, referred to as the Beijing-Tianjin-Hebei Joint Mining Platform, the same below)
.

Seven, the main work process

(1) Collect centralized procurement product and price data
.

In view of the fact that relevant companies have already filled in relevant product prices and other information as required by the Beijing Municipal Pharmaceutical Centralized Purchasing Service Center, the Beijing-Tianjin-Hebei "3+N" Alliance Medical Security Department has researched and decided: For relevant product prices and other information that have already been filled in, they should be directly imported into Beijing The Tianjin-Hebei "3+N" alliance medical consumables with quantity linkage procurement project is used as the basic data information of this project
.
If the data is incomplete or the information is incomplete, it needs to be supplemented in accordance with relevant requirements
.

(2) The enterprise shall fill in the proposed supply price and estimated supply volume of the participating products
.

The applicant company logs on to the Beijing platform to view the product information of the company participating in this project.
Among them, for the products that have been declared for the linkage purchase of coronary drug balloons in Beijing, in principle, they will be directly transferred to this Beijing-Tianjin-Hebei "3+" N" Alliance Coronary Drug Balloon Medical Consumables is the selected result of the linkage procurement
.
For pacemaker medical consumables, fill in the proposed supply price of each product according to the following requirements: First, the proposed supply price declared by the enterprise shall not be higher than the current purchase price of the procurement entities in the Beijing-Tianjin-Hebei "3+N" alliance; second, for other regions For pacemaker products selected in volume procurement, the proposed supply price reported by the company shall not be higher than the lowest price of the product selected in volume procurement in other regions in principle; third, for pacemakers not selected in volume procurement in other regions In principle, the proposed supply price reported by the enterprise shall not be higher than the average price level of the lowest price selected for the same functional attributes and the same group of products in various regions with volume purchases
.
At the same time, the company fills in the estimated supply in the coming year for the reference of the purchaser
.

(3) Collect historical procurement data and intended procurement volume of procurement entities
.

Under the coordination and guidance of the regional medical security department of the Beijing-Tianjin-Hebei "3+N" alliance, procurement entities from all regions log on to the Beijing-Tianjin-Hebei Joint Procurement Platform and fill in all coronary drug balloons and pacing for the whole year of 2020 and the first half of 2021.
The historical purchase price and corresponding purchase quantity of the device are specific to the specifications and models
.
The purchasing entity shall fill in the purchasing demand for coronary drug balloons and pacemaker products in the next year with reference to historical purchasing volume, clinical use status, medical technology progress, and expected supply volume declared by the enterprise, which is specific to the purchasing unit
.
When filling in, the authorization letter confirmed by the purchaser's signature and seal should be uploaded at the same time
.

Combined with the national provincial (or alliance) selection of the selected product, in principle, a certain proportion of the total demand reported by the purchaser will be used as the intentional purchase volume for this volume-linked procurement, of which, in 0-1 provinces (or alliances) 70% are selected, and 80% are selected from 2 or more provinces (or alliances)
.

(4) Two-way selection between the declaring enterprise and the purchasing entity, forming the selected products and subcontracting tasks
.

The declaring company will log in to the Beijing platform to confirm the supply intentions according to the purchasing entity’s intention to purchase volume, combined with its own supply capabilities, and complete the selection of both the enterprise and the purchasing entity, and generate the selected products and product subcontracting tasks
.

In the two-way selection process, the products that are confirmed to be supplied by the applicant enterprise are the selected products, and the corresponding subcontracting tasks are formed
.
For the declared enterprise that refuses to supply, the corresponding intended purchase volume is regarded as the amount to be allocated, and the purchasing entity is re-allocated to other declared products that meet the conditions and functional attributes.
If it is allocated to the declared product that has been confirmed for supply in the previous round, the company cannot refuse to supply in principle.
, That is, the two-way selection is completed; if the declared product is allocated to the declared product for which the intended purchase volume has not been allocated in the previous round, the declaring company will continue to confirm the supply intention until all the intended purchase volume has completed the two-way selection
.

(5) Sign a quantity purchase agreement and implement online purchases
.

Each territorial medical security department organizes the procurement subject, the selected company, and the distribution company determined by the selected company to sign a tripartite agreement for purchase and sale at the selected price
.
Agreement should clearly selected number of products, supply price, delivery time, payment agreement, breach of contract and so on
.
Purchasing entities should strictly implement online procurement of medical consumables in accordance with the requirements of the territorial medical security department
.
The actual implementation date and supporting policies of the selected results will be determined by the local medical security department
.

8.
Purchasing requirements

(1) During the procurement cycle, the procurement entity shall give priority to the use of the selected products in this volume-based linkage procurement and ensure that the agreed procurement volume is completed
.
When there are major changes in clinical demand or supply, such as medical technology advancement, actual purchases exceed the company's expected supply, etc.
, the purchase and sale parties are allowed to adjust the number of agreements between different specifications and models of the same group and the same company
.
On this basis, the purchaser can purchase other appropriate coronary drug balloons and pacemakers in appropriate quantities in accordance with the relevant regulations of the centralized procurement management of medical consumables in the region
.
Companies that have newly obtained registration certificates for unlinked products can apply for listing
.

(2) During the procurement cycle, the selected company should give priority to supplying the procurement subject’s current contracted purchase volume, and the part of the current contracted procurement volume beyond the scope of the agreement subject still needs to be supplied at the selected price until the expiration of the procurement cycle, and further expand the selection Product market share and improve the availability of selected products
.

(3) Implement price linkage for selected products during the procurement cycle
.
If the selected price for volume purchase in other regions is lower than the price selected for volume linkage purchase, the selected company shall declare a new minimum price to the "Beijing-Tianjin-Hebei Purchasing Center" within 30 days and implement price linkage
.
Enterprises that fail to report in time or make false declarations shall be dealt with in accordance with relevant regulations
.

Nine, contact information

Beijing Medical Centralized Procurement Service Center

Contact number: 010-89152634

Fax: 010-89152614

Service hours: 9:00-11:30, 13:30-17:00, except holidays
.

Tianjin Pharmaceutical Purchasing Center

Contact number: 022-24538156

Fax: 022-24538991

Service hours: 9:00-12:00, 13:30-16:30, except holidays
.

Hebei Province Medical Drug Equipment Centralized Procurement Center

Contact number: 0311-66906539

Fax: 0311-66906539

Service hours: 9:00-12:00, 13:30-16:30, except holidays
.

Beijing Medical Centralized Procurement Service Center

Tianjin Pharmaceutical Purchasing Center

Hebei Province Medical Drug Equipment Centralized Procurement Center

September 8 2021